Cargando…
The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
SIMPLE SUMMARY: The study investigates the potential use of metformin, a medication commonly prescribed for type 2 diabetes, in the treatment of hepatocellular carcinoma (HCC). Metformin has been gaining attention for its possible anticancer properties beyond its antidiabetic effects. The study expl...
Autores principales: | Papadakos, Stavros P., Ferraro, Daniele, Carbone, Gabriele, Frampton, Adam Enver, Vennarecci, Giovanni, Kykalos, Stylianos, Schizas, Dimitrios, Theocharis, Stamatios, Machairas, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295995/ https://www.ncbi.nlm.nih.gov/pubmed/37370771 http://dx.doi.org/10.3390/cancers15123161 |
Ejemplares similares
-
Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation
por: Papadakos, Stavros P., et al.
Publicado: (2023) -
The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
por: Papadakos, Stavros P., et al.
Publicado: (2022) -
The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
por: Papadakos, Stavros P., et al.
Publicado: (2023) -
Laparoscopic parastomal hernia repair: keyhole, Sugarbaker, sandwich, or hybrid technique with 3D mesh? An updated systematic review and meta-analysis
por: Kritharides, Nicos, et al.
Publicado: (2023) -
Repurposing Metformin for Vascular Disease
por: Triggle, Chris R., et al.
Publicado: (2023)